Recalls & Warnings December 20, 2017 Seller of Supplements for Pain and Allergies Warned for Manufacturing Violations, Drug Claims On December 13, 2017, the FDA issued a warning letter to GnuPharma Corporation, following a facility inspection which found a number of the company's products, including Relief capsules, Foundation capsules, Aller-geez capsules, Fit capsules, Aller-Geez Tea, Foundation herbal tea and
28 days is the FDA requirement for producers of multi-use vials to prove their bacteriostatic maintains efficacy
Adipose-tissue gene expression laboratory studies have profiled changes in genes associated with lipolysis, -oxidation and adipogenesis following AOD-9604 exposure
We will review your goals, activity level, and health history, then map out a recovery plan
A total of 276 respondents said the decisions to change treatment were mostly initiated by a healthcare professional with no further discussion with the patient